Boston Scientific has committed to serve as an official Global Partner for the World Thrombosis Day.
A year-long campaign recognized on 13 October, World Thrombosis Day focuses attention on the often overlooked and misunderstood condition of thrombosis. With thousands of educational events in more than 80 countries around the world, World Thrombosis Day and its partners place a global spotlight on thrombosis as an urgent and growing health problem. Together, the collaboration aims to reduce death and disability caused by thrombosis.
In its third year, the World Thrombosis Day campaign seeks to ensure citizens of the world “Know Thrombosis” and understand the steps to take to “Keep Life Flowing.” Based on a global survey conducted in nine countries among men and women, too few people know about thrombosis, specifically blood clots in the leg (deep vein thrombosis) and lungs (pulmonary embolism) and their life-threatening consequences. The campaign urges people to: 1) Know the risk factors; 2) Know the signs and symptoms; 3) Be proactive and talk to a health care professional about risk and prevention of blood clots, especially if admitted to the hospital or having surgery.
For more information about World Thrombosis Day, visit www.worldthrombosisday.org.
About World Thrombosis Day
Launched in 2014 and held annually on 13 October, World Thrombosis Day (WTD) aims to increase public, healthcare professional and health care systems’ awareness of thrombosis and, ultimately, to reduce deaths and disabilities from thromboembolic disease through a greater awareness of its causes, risk factors, signs and symptoms, and evidence-based prevention and treatment. WTD’s mission supports the World Health Assembly's global target of reducing premature deaths by non-communicable disease by 25 percent by 2025, as well as the WHO global action plan for the prevention and control of non-communicable diseases in the 2013-2020 timeframe. Unrestricted corporate grants to help support WTD come from Bayer HealthCare, Boehringer Ingelheim, Boston Scientific, Bristol-Myers Squibb/Pfizer Alliance, Daiichi Sankyo, Janssen and Portola Pharmaceuticals; and global patron Medtronic. Visit www.worldthrombosisday.org for more information.
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.eu and connect on Twitter and Facebook.